MUPIROCIN OINTMENT

The Defense Logistics Agency awarded a delivery order, SPE2DP26F7667, to DMS Pharmaceutical Group Inc. under the basic contract SPE2DX25D9900 for the supply of 4 treatment units of Mupirocin Ointment, identified by NSN 6505014805678, at a total value of $27.84. The award was issued on July 14, 2026, with delivery required by July 29, 2026, to Fort Stewart, Georgia, under FOB Destination terms, meaning the contractor bears all costs and risks until delivery at the destination. The contractor, identified by CAGE code 1UNB0, is certified as a small business, small disadvantaged business, and women-owned small business, triggering compliance obligations under FAR 19 for program reporting. The ointment must be shipped via traceable means, with parcel post prohibited, and all packaging and documentation must be clearly marked with the CAGE code, NDC number, and tracking identifier using block printing for traceability. Inspection and acceptance are conducted by the government at the delivery point, with no specific quality or packaging standards referenced beyond contractual conformity. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, using the provided accounting data. The contracting officer is Lisa Quinn, but no Contracting Officer’s Representative is named. No formal FAR clauses, DFARS provisions, MIL-STD references, barcoding specifications, or detailed technical specifications are included in the documentation, indicating a streamlined, low-value procurement governed primarily by delivery, marking, and acceptance terms under the overarching basic contract.